Versant Vantage I, L.P., 10% Owner at Repare Therapeutics Inc. (RPTX), sold 1,296,753 shares at $12.25 ($15.3M) on 2022-06-03, disclosed to the SEC on 2022-06-07.
Open-market sale of $15.3M RPTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.25 | 13,199 | $162K | 1.1% |
| 2 | $12.25 | 13,199 | $162K | 1.1% |
| 3 | $12.25 | 14,611 | $179K | 1.2% |
| 4 | $12.25 | 14,611 | $179K | 1.2% |
| 5 | $12.25 | 33,395 | $409K | 2.7% |
| 6 | $12.25 | 33,395 |
| $409K |
| 2.7% |
| 7 | $12.25 | 250,000 | $3.1M | 20.0% |
| 8 | $12.25 | 438,795 | $5.4M | 35.1% |
| 9 | $12.25 | 438,795 | $5.4M | 35.1% |
| 10 | $0.00 | 46,753 | $0 | 0.0% |
| Total | $11.81 avg | 1,296,753 | $15.3M | 100% |
| Filing → |
| BDTX | SELL | 2020-11-12 | $2.6M | — | Filing → |
| BDTX | SELL | 2020-11-10 | $586K | — | Filing → |
| RPTX | BUY | 2020-06-25 | $5.0M | — | Filing → |